Immunomodulation as therapy for fungal infection: Are we closer?

10.3389/fmicb.2018.01612

Saved in:
Bibliographic Details
Main Authors: Sam, Q.H., Yew, W.S., Seneviratne, C.J., Chang, M.W., Chai, L.Y.A.
Other Authors: BIOCHEMISTRY
Format: Review
Published: Frontiers Media S.A. 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/174534
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-174534
record_format dspace
spelling sg-nus-scholar.10635-1745342024-04-24T05:54:31Z Immunomodulation as therapy for fungal infection: Are we closer? Sam, Q.H. Yew, W.S. Seneviratne, C.J. Chang, M.W. Chai, L.Y.A. BIOCHEMISTRY DENTISTRY MEDICINE auranofin colony stimulating factor 1 cytokine receptor agonist deferasirox ebselen efungumab gamma interferon granulocyte colony stimulating factor granulocyte macrophage colony stimulating factor interleukin 12p40 interleukin 6 molgramostim probiotic agent recombinant gamma interferon recombinant granulocyte macrophage colony stimulating factor retinol sargramostim suppressor of cytokine signaling 3 tamoxifen toll like receptor 9 toll like receptor agonist tumor necrosis factor vitamin D adoptive T cell therapy antifungal therapy cell therapy chimeric antigen receptor natural killer cell immunotherapy chimeric antigen receptor T-cell immunotherapy clinical trial (topic) cryptococcal meningitis cryptococcosis Cryptococcus neoformans drug repositioning granulocyte transfusion human immunomodulation microbiome nonhuman phase 1 clinical trial (topic) phase 2 clinical trial (topic) Review systemic mycosis T lymphocyte 10.3389/fmicb.2018.01612 Frontiers in Microbiology 9 JUL 1612 2020-09-07T05:05:10Z 2020-09-07T05:05:10Z 2018 Review Sam, Q.H., Yew, W.S., Seneviratne, C.J., Chang, M.W., Chai, L.Y.A. (2018). Immunomodulation as therapy for fungal infection: Are we closer?. Frontiers in Microbiology 9 (JUL) : 1612. ScholarBank@NUS Repository. https://doi.org/10.3389/fmicb.2018.01612 1664302X https://scholarbank.nus.edu.sg/handle/10635/174534 Frontiers Media S.A. Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic auranofin
colony stimulating factor 1
cytokine receptor agonist
deferasirox
ebselen
efungumab
gamma interferon
granulocyte colony stimulating factor
granulocyte macrophage colony stimulating factor
interleukin 12p40
interleukin 6
molgramostim
probiotic agent
recombinant gamma interferon
recombinant granulocyte macrophage colony stimulating factor
retinol
sargramostim
suppressor of cytokine signaling 3
tamoxifen
toll like receptor 9
toll like receptor agonist
tumor necrosis factor
vitamin D
adoptive T cell therapy
antifungal therapy
cell therapy
chimeric antigen receptor natural killer cell immunotherapy
chimeric antigen receptor T-cell immunotherapy
clinical trial (topic)
cryptococcal meningitis
cryptococcosis
Cryptococcus neoformans
drug repositioning
granulocyte transfusion
human
immunomodulation
microbiome
nonhuman
phase 1 clinical trial (topic)
phase 2 clinical trial (topic)
Review
systemic mycosis
T lymphocyte
spellingShingle auranofin
colony stimulating factor 1
cytokine receptor agonist
deferasirox
ebselen
efungumab
gamma interferon
granulocyte colony stimulating factor
granulocyte macrophage colony stimulating factor
interleukin 12p40
interleukin 6
molgramostim
probiotic agent
recombinant gamma interferon
recombinant granulocyte macrophage colony stimulating factor
retinol
sargramostim
suppressor of cytokine signaling 3
tamoxifen
toll like receptor 9
toll like receptor agonist
tumor necrosis factor
vitamin D
adoptive T cell therapy
antifungal therapy
cell therapy
chimeric antigen receptor natural killer cell immunotherapy
chimeric antigen receptor T-cell immunotherapy
clinical trial (topic)
cryptococcal meningitis
cryptococcosis
Cryptococcus neoformans
drug repositioning
granulocyte transfusion
human
immunomodulation
microbiome
nonhuman
phase 1 clinical trial (topic)
phase 2 clinical trial (topic)
Review
systemic mycosis
T lymphocyte
Sam, Q.H.
Yew, W.S.
Seneviratne, C.J.
Chang, M.W.
Chai, L.Y.A.
Immunomodulation as therapy for fungal infection: Are we closer?
description 10.3389/fmicb.2018.01612
author2 BIOCHEMISTRY
author_facet BIOCHEMISTRY
Sam, Q.H.
Yew, W.S.
Seneviratne, C.J.
Chang, M.W.
Chai, L.Y.A.
format Review
author Sam, Q.H.
Yew, W.S.
Seneviratne, C.J.
Chang, M.W.
Chai, L.Y.A.
author_sort Sam, Q.H.
title Immunomodulation as therapy for fungal infection: Are we closer?
title_short Immunomodulation as therapy for fungal infection: Are we closer?
title_full Immunomodulation as therapy for fungal infection: Are we closer?
title_fullStr Immunomodulation as therapy for fungal infection: Are we closer?
title_full_unstemmed Immunomodulation as therapy for fungal infection: Are we closer?
title_sort immunomodulation as therapy for fungal infection: are we closer?
publisher Frontiers Media S.A.
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/174534
_version_ 1800914252302647296